US3630957A - Diagnostic agent - Google Patents
Diagnostic agent Download PDFInfo
- Publication number
- US3630957A US3630957A US683129A US3630957DA US3630957A US 3630957 A US3630957 A US 3630957A US 683129 A US683129 A US 683129A US 3630957D A US3630957D A US 3630957DA US 3630957 A US3630957 A US 3630957A
- Authority
- US
- United States
- Prior art keywords
- film
- diagnostic agent
- water
- polyvinyl
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940039227 diagnostic agent Drugs 0.000 title abstract description 46
- 239000000032 diagnostic agent Substances 0.000 title abstract description 46
- 239000000203 mixture Substances 0.000 abstract description 34
- 238000001514 detection method Methods 0.000 abstract description 26
- 239000000126 substance Substances 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 20
- 210000002700 urine Anatomy 0.000 abstract description 18
- 239000013060 biological fluid Substances 0.000 abstract description 16
- 230000004044 response Effects 0.000 abstract description 4
- 239000011888 foil Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000003153 chemical reaction reagent Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 22
- 229920002554 vinyl polymer Polymers 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 19
- 229910052708 sodium Inorganic materials 0.000 description 19
- 239000011734 sodium Substances 0.000 description 19
- 239000000123 paper Substances 0.000 description 16
- 239000006185 dispersion Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 229920002678 cellulose Polymers 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000001913 cellulose Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 229920003002 synthetic resin Polymers 0.000 description 8
- 239000000057 synthetic resin Substances 0.000 description 8
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 108010015776 Glucose oxidase Proteins 0.000 description 6
- 239000004366 Glucose oxidase Substances 0.000 description 6
- 102000003992 Peroxidases Human genes 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 229940116332 glucose oxidase Drugs 0.000 description 6
- 235000019420 glucose oxidase Nutrition 0.000 description 6
- 229920000915 polyvinyl chloride Polymers 0.000 description 6
- 239000004800 polyvinyl chloride Substances 0.000 description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229920003086 cellulose ether Polymers 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920001290 polyvinyl ester Polymers 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 2
- BOTGCZBEERTTDQ-UHFFFAOYSA-N 4-Methoxy-1-naphthol Chemical compound C1=CC=C2C(OC)=CC=C(O)C2=C1 BOTGCZBEERTTDQ-UHFFFAOYSA-N 0.000 description 2
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 2
- 229940081735 acetylcellulose Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- -1 for example chalk Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 229920005613 synthetic organic polymer Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001005836 Euchloe ausonia Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 229920002398 Oppanol® B Polymers 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/146666—Bile pigment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/171538—Urea or blood urea nitrogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/173076—Nitrite or nitrate
Definitions
- the present invention relates to a new and improved diagnostic agent for use in the detection of chemical and biochemical components in biological fluids, and more particularly relates to test strips for use in the detection of chemical and biochemical components of biological fluids, a process of preparing such test strips and methods for using the same.
- test papers with a semi-permeable film and/or membrane or to hydrophobe impregnated and dried papers.
- these test papers can only be produced by multiple impregnations of filter papers which not only results in technical difliculties from the point of view of production, but also increases their cost considerably. Further, as with an increasing number of process steps, the possible number of production errors increases; either the reliability of the resultant test paper is reduced or additional intermediate controls are necessary, which are of course in and of themselves expensive.
- a new and improved diagnostic agent i.e., test strip for use in detecting chemical and biochemical components present, for example, in biological fluids such as blood, urine, etc. and other fluids such as milk, etc.
- a further object of the invention is to provide a new and improved diagnostic agent for use in detecting chemical and biochemical components present in biological fluids characterized by the extreme case with which they are produced and used, as well as by their reliability, i.e., accuracy and reproducibility of results.
- Still another object of this invention is to provide a new and improved diagnostic agent for safely and reliably detecting single or multiple chemical and biochemical components in biological fluids.
- diagnostic agents for the detection of biochemical and chemical components in biological fluids which are outstandingly useful and reliable and can be prepared in an economically feasible manner, are obtained by introducing the specific reagents and/or indicators necessary for a detection reaction into a solution or dispersion of the film-forming materials, i.e., the materials required for making the water-resistant films.
- the film-forming mixture is applied either to a non-retaining substrate or to a substrate to which the film adheres firmly, and the coated or layered substrate is then dried.
- the film can subsequently be removed, as for example by stripping, from the substrate, whereas in the second case, the substrate serves as a carrier for the film so that in this instance the film itself may be mechanically less stable and thinner.
- the diagnostic agents according to the present invention for use in the detection of chemical or biochemical components in biological fluids comprises a waterresistant film in which the reagents for the detection reaction are substantially uniformly distributed, the film possibly being supported on a substrate.
- film-forming agents there can be used those materials which are soluble in organic solvents or which can be dispersed in water, such as cellulose ethers, cellulose esters, cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide, polyamides and other film-forming, natural or synthetic polymers, as well as mixtures thereof.
- cellulose ethers cellulose esters, cellulose acetate phthalate
- polyvinyl esters polyvinyl acetals
- polyacrylic esters polyacrylamide
- polyamides polyamides and other film-forming, natural or synthetic polymers, as well as mixtures thereof.
- Ethyl cellulose, acetyl cellulose, polyvinyl acetate, polyvinyl propionate, polyvinyl butyracetal and latex have proved to be especially useful.
- synthetic resin foils As carriers or supports (substrates) for coating with the films, it is preferred to use synthetic resin foils but it is also possible to use, for example, glass, wood, paper, metal foils and other like materials.
- the film-forming compositions can also contain any of the conventional fillers and adjuvants, such as for example chalk, titanium dioxide, silica gel, starch, talc, pearl white, metal soaps, cellulose powder and the like, as well as suitable thickening agents, emulsifiers, dispersion agents, plasticizers and the like. Pigments can also be included in the films and serve to render the same opaque.
- the resultant films can be applied to a colored carrier material; in this manner, the reagent foils, in contradistinction to completely transparent foils, can be compared directly with color charts without porcelain tiles or the like being necessary.
- composition of the reagents is, in principle, the same as in the case of the previously known diagnostic agents.
- the presence of glucose can be detected with the use of a mixture of glucose oxidase, peroxidase, buffer and color-forming agent; for the detection of blood in urine, there can be used a mixture of peroxide and a color-forming agent and urobilinogen can be detected with p-dialkylamino-benzaldehyde and a strong acid.
- test papers and indicator foils consist of the same material, namely, cellulose. Since the synthetic resin films according to the present invention can be made from the most varied materials, the most compatible and best suited material for each special purpose can be selected.
- the materials used according to the present invention can be worked up much more easily with constant quality, are more homogeneous; and consequently are more dependable. Furthermore, We have found that not only the mechanical stability of the foils, but in addition the stability of the reagents is better than in the case of test papers. Even after the reaction has taken place with the body fluid being analyzed, the new test foils according to the present invention are considerably more stable than the previously used test papers so that the results obtained can, if desired, be evaluated at a later time or can even be checked after several days.
- diagnostic agents according to the present invention for the detection of glucose in blood or urine can be enclosed with a patients examination report and can be filed away with the records relating to the findings in the patients file history.
- the production of the new diagnostic agents according to the present invention takes place, in the simplest way, by the application of the film-forming solution or dispersion to a suitable substrate, followed by drying.
- the film-forming solution or dispersion to a suitable substrate, followed by drying.
- the resultant foil is cut at right angles to the direction of application, to thereby provide narrow strips suitable for simultaneously detecting a variety of components, i.e., there are obtained multi-test strips.
- the synthetic resin films according to the present invention can be produced having any desired thickness and with any desired reagent concentration. Since the reagents also cannot be leached out or non-uniformly distributed by chromatographic effects, the fluid to be investigated can, if desired, be left to act upon the film for a comparatively long period of time, a stronger color reaction thereby being produced. Therefore, the new diagnostic agents according to the present invention can be used not only for the previously known test reactions but also for those which, because of the known disadvantages of test papers, have hitherto not been capable of being made up into the considerably simpler and easier used form of a test strip.
- EXAMPLE 1 A reagent film for the detection of glucose in, for example, urine or whole blood, was prepared as follows: A mixture having the following composition was first prepared:
- EXAMPLE 2 For the production of a reagent foil for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
- a 500a thick layer of the above mixture was applied onto a white polyvinyl chloride foil and the foil thereafter dried with warm air. There was obtained a water-insoluble film, the properties of which corresponded to those of the film described in Example 1.
- a diagnostic agent for use in the detection of blood in urine was prepared as follows: A mixture having the following composition was prepared:
- the above mixture was applied onto a polyvinyl chloride foil so as to provide a 500; thick layer and the thusly treated foil is then dried with warm air. There was obtained a water-insoluble film which, upon being immersed into blood-containing urine, provided a more or less strong color, corresponding to the concentration of blood in the urine specimen.
- the mixture was then applied to a polyvinyl chloride foil so as to produce a 300,11. thick layer and the layered foil was then dried with warm air. There was obtained a water-insoluble film which, on being moistened with urobilinogen-containing urine, evidenced a more or less dark red color, depending upon the urobilinogen con centration.
- EXAMPLE 6 For the production of a regagent film for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
- the mixture was then applied to a white polyvinyl chloride foil so as to provide a 300 thick layer of the mixture, and the thusly layered foil dried with warm air. There was obtained a water-insoluble film which on reaction with glucose, for example, in blood in a concentration within the range of 50-250 mg. percent evidenced a strong color.
- EXAMPLE 7 90 g. of an aqueous dispersion of polyvinyl propionate (Propiofan), 1.3 g. of the sodium salt of a polymannuronic acid (Algipon), 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate (Texapon P), 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxynaphthalene in 20 ml. methanol were stirred together to form a homogeneous mixture. This mixture was then applied onto a foil to provide a layer thereof having a thickness of 300 2 and the layered foil dried.
- Algipon polymannuronic acid
- Texapon P organic sodium sulfonate
- Propiofan, Algipon, and Texapon P are trademarks of BASF, Henkel and Dehydag respectively.
- EXAMPLE 8 g. of polyvinyl propionate dispersion (Propiofan), 35 g. of a 1.85% solution of polymannuronic acid (Algipon) in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate (Texapon), 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9-ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, were stirred to form a homogeneous slurry. 0.50 ml.
- a diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which said color forming reagent is uniformly dispersed throughout the film.
- a diagnostic agent according to claim 1 including a carrier support for said film.
- a diagnostic agent according to claim 2 wherein said film is firmly attached to said carrier support to form an integral structure therewith.
- a diagnostic agent according to claim 2 wherein said carrier support is a member selected from the group consisting of glass, paper, asbestos, wood, metal and synthetic resins inert to the biological fluid.
- a diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one polymer selected from the group consisting of polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamides and polyamides.
- a diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one member selected from the group consisting of cellulose ethers and cellulose esters.
- a diagnostic agent according to claim 6 wherein the said member is polyvinyl acetate, polyvinyl propionate or polyvinyl butyracetal.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion100.00 g. o-Vanillin-(vanilloyl)-hydrazone2.50 g. Glucose oxidase0.06 g.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises Ethyl cellulose-35.00 g. o-Vanillin-(vanilloyl) -hydrazone1.7 g. Glucose oxidase0.04 g.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises o-Tolidine-0.25 g.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises p-Dimethylamino-benzaldehyde-l .0 g. Orthophosphoric acid )20.0 g. Polyvinyl acetal20.0 g.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises a-Naphthylamine1.0 g. Sulfanilamide-2.5 g. Trichloroacetic acid3.0 g. Polyvinyl butyracetal20.0 g. Methanol-100.0 ml.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion45 .0 g. Phosphate buffer 0.4 M (pH 5.5)45.0 ml. Sodium alginate0.5 g.
- said water-resistant film comprises g. of an aqueous dispersion of polyvinyl propionate, 1.3 g. of the sodium salt of a polymannuronic acid, 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate, 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxy-naphthalene in 20 ml. methanol, in dried form.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises 45 g. of a polyvinyl propionate dispersion, 35 g. of a 1.85% solution of polymannuronic acid in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate, 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9- ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, in dried form.
- a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyisobutylene dispersion 22.50 Sodium alginate solution (1.85%) in 0.15 M
- Method of detecting a chemical or biochemical component in a biological fluid which comprises contacting a diagnostic agent according to claim 1 with said fluid and comparing the color of said diagnostic agent with a standard.
- a diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer selected from the group consistiing of cellulose ethers, cellulose esters cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide and polyamides, and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which the color forming reagent is uniformly dispersed throughout the film.
- a natural or synthetic organic polymer selected from the group consistiing of cellulose ethers, cellulose esters cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide and polyamides, and a color forming reagent capable of producing color in response to the presence of a chemical or bio
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0089944 | 1966-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3630957A true US3630957A (en) | 1971-12-28 |
Family
ID=6985034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US683129A Expired - Lifetime US3630957A (en) | 1966-11-22 | 1967-11-15 | Diagnostic agent |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3630957A (enExample) |
| JP (1) | JPS4933800B1 (enExample) |
| AT (1) | AT282832B (enExample) |
| BR (1) | BR6794865D0 (enExample) |
| CH (1) | CH480634A (enExample) |
| CY (1) | CY789A (enExample) |
| DE (1) | DE1598153C3 (enExample) |
| FI (1) | FI48306C (enExample) |
| GB (1) | GB1159627A (enExample) |
| GR (1) | GR38283B (enExample) |
| NL (1) | NL145048B (enExample) |
| SE (1) | SE413439B (enExample) |
Cited By (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3897214A (en) * | 1971-11-24 | 1975-07-29 | Boehringer Mannheim Gmbh | Diagnostic device |
| US3975162A (en) * | 1974-03-13 | 1976-08-17 | Marine Colloids, Inc. | Applying reagent to medium and device therefor |
| US4020006A (en) * | 1975-08-14 | 1977-04-26 | Icl/Scientific | Fluid containing dispersed particles simulating leukocytes and method for producing same |
| DE2614192A1 (de) * | 1976-04-02 | 1977-10-20 | Marine Colloids Inc | Analysenvorrichtung und analysenverfahren |
| US4066403A (en) * | 1975-06-20 | 1978-01-03 | Eastman Kodak Company | Multilayer analytical element |
| US4175923A (en) * | 1978-06-26 | 1979-11-27 | Friend William G | Method and apparatus for occult blood testing in the home |
| USRE30267E (en) * | 1975-06-20 | 1980-05-06 | Eastman Kodak Company | Multilayer analytical element |
| US4283491A (en) * | 1977-09-06 | 1981-08-11 | Eastman Kodak Company | Analytical elements with improved reagent stability |
| US4298498A (en) * | 1978-12-21 | 1981-11-03 | Boehringer Mannheim Gmbh | Control reagent for test strips for determining urobilinogen in urine |
| US4303753A (en) * | 1980-03-20 | 1981-12-01 | Miles Laboratories, Inc. | Method and device for the semiquantitative determination of glucose in aqueous fluids |
| US4312834A (en) * | 1979-03-15 | 1982-01-26 | Boehringer Mannheim Gmbh | Diagnostic agent for the detection of component materials in liquid and process for producing same |
| US4318985A (en) * | 1981-01-29 | 1982-03-09 | Miles Laboratories, Inc. | Method and device for detecting glucose concentration |
| US4388271A (en) * | 1980-01-10 | 1983-06-14 | Rohm Gmbh | Rapid diagnostic agents |
| DE2950501C1 (de) * | 1978-05-17 | 1983-07-07 | Battelle Memorial Institute, 1227 Carouge, Genève | Teststreifan |
| EP0110173A1 (en) | 1982-11-01 | 1984-06-13 | Lifescan, Inc. | Test device and method for in a colored aqueous fluid by diffuse reflectance detecting a soluble analyte measurement |
| US4543338A (en) * | 1983-06-03 | 1985-09-24 | Miles Laboratories, Inc. | Wipe-off test device |
| US4582811A (en) * | 1983-02-02 | 1986-04-15 | Australian Monoclonal Development Pty. Ltd. | Method and diagnostic aid for detecting occult faecal blood |
| US4587099A (en) * | 1981-05-09 | 1986-05-06 | Boehringer Mannheim Gmbh | Test strips for the detection of a liquid sample component |
| US4621049A (en) * | 1984-11-19 | 1986-11-04 | Miles Laboratories, Inc. | Enzymatic high range glucose test |
| US4645744A (en) * | 1983-05-12 | 1987-02-24 | Miles Laboratories, Inc. | Unified test means for ion determination |
| US4670218A (en) * | 1984-02-24 | 1987-06-02 | Miles Laboratories, Inc. | Ion test means having a porous carrier matrix |
| US4734375A (en) * | 1980-05-27 | 1988-03-29 | Miles Laboratories, Inc. | Ion specific test method |
| WO1988005912A1 (en) * | 1987-01-28 | 1988-08-11 | Technimed Corporation | Dry reagent delivery system |
| US4780411A (en) * | 1984-09-22 | 1988-10-25 | Bayer Aktiengesellschaft | Water-absorbing, essentially water-free membrane for reagent substrates and methods of preparing the same |
| US4803158A (en) * | 1983-03-08 | 1989-02-07 | Kabushiki Kaisha Kyoto Daiichi Kagaku | Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition |
| US4810633A (en) * | 1984-06-04 | 1989-03-07 | Miles Inc. | Enzymatic ethanol test |
| US4816224A (en) * | 1980-08-05 | 1989-03-28 | Boehringer Mannheim Gmbh | Device for separating plasma or serum from whole blood and analyzing the same |
| US4820489A (en) * | 1982-12-23 | 1989-04-11 | Boehringer Mannheim Gmbh | Test strips and a process for the production thereof |
| US4883764A (en) * | 1987-07-20 | 1989-11-28 | Kloepfer Mary A | Blood test strip |
| US4895704A (en) * | 1985-04-23 | 1990-01-23 | Fuji Photo Film Co., Ltd. | Integral multilayer analytical element |
| EP0371513A2 (en) | 1988-12-01 | 1990-06-06 | Kyoto Daiichi Kagaku Co., Ltd. | Device and method for assay of liquid sample |
| US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US4935347A (en) * | 1976-01-12 | 1990-06-19 | Radiometer Corporate Development Ltd. | Stabilization of compounds |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| US4966855A (en) * | 1984-07-07 | 1990-10-30 | Boehringer Mannheim Gmbh | New redox indicators |
| US4994238A (en) * | 1988-06-09 | 1991-02-19 | Daffern George M | Constant volume chemical analysis test device |
| US5055195A (en) * | 1983-07-02 | 1991-10-08 | Boehringer Mannheim Gmbh | Erythrocyte-retention substrates |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US5106581A (en) * | 1991-05-30 | 1992-04-21 | Industrial Test Systems, Inc. | Test device for detection of molybdate, vanadate and ferric ions |
| US5106757A (en) * | 1989-02-25 | 1992-04-21 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Process for the visualization of substance stains on layer chromatograms |
| US5186843A (en) * | 1991-07-22 | 1993-02-16 | Ahlstrom Filtration, Inc. | Blood separation media and method for separating plasma from whole blood |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US5304467A (en) * | 1988-11-30 | 1994-04-19 | Kyoto Daiichi Kagaku Co., Ltd. | Device for assay of liquid sample |
| US5536470A (en) * | 1991-02-28 | 1996-07-16 | Boehringer Mannheim Gmbh | Test carrier for determining an analyte in whole blood |
| US5660798A (en) * | 1993-04-20 | 1997-08-26 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
| US5681529A (en) * | 1994-08-25 | 1997-10-28 | Nihon Medi-Physics Co., Ltd. | Biological fluid analyzing device |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| US5766552A (en) * | 1993-04-20 | 1998-06-16 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
| US5962215A (en) * | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
| US6036919A (en) * | 1996-07-23 | 2000-03-14 | Roche Diagnostic Gmbh | Diagnostic test carrier with multilayer field |
| US6069011A (en) * | 1997-12-10 | 2000-05-30 | Umm Electronics, Inc. | Method for determining the application of a sample fluid on an analyte strip using first and second derivatives |
| US6162397A (en) * | 1998-08-13 | 2000-12-19 | Lifescan, Inc. | Visual blood glucose test strip |
| DE19826957C2 (de) * | 1997-06-17 | 2001-11-08 | Mercury Diagnostics Inc | Vorrichtung zum Bestimmen eines Analyten in einem Körperfluid |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US20030003522A1 (en) * | 2001-06-29 | 2003-01-02 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US20030098661A1 (en) * | 2001-11-29 | 2003-05-29 | Ken Stewart-Smith | Control system for vehicle seats |
| US6635439B2 (en) | 2000-12-21 | 2003-10-21 | Ethicon, Inc. | Hydrogen peroxide indicator employing enzyme and dye |
| US20040074768A1 (en) * | 2002-10-18 | 2004-04-22 | Anex Deon S. | Electrokinetic pump having capacitive electrodes |
| US20040116829A1 (en) * | 2001-06-08 | 2004-06-17 | Raney Charles C. | Sampling devices and methods utilizing a horizontal capillary test strip |
| US20040191119A1 (en) * | 2003-03-24 | 2004-09-30 | Zanzucchi Peter J. | Analyte concentration detection devices and methods |
| US20050039747A1 (en) * | 2001-09-24 | 2005-02-24 | Fukunaga Atsuo F. | Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases |
| US20050230080A1 (en) * | 2004-04-19 | 2005-10-20 | Paul Phillip H | Electrokinetic pump driven heat transfer system |
| US20050247558A1 (en) * | 2002-07-17 | 2005-11-10 | Anex Deon S | Electrokinetic delivery systems, devices and methods |
| US7049130B2 (en) | 1997-06-10 | 2006-05-23 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
| US20060281187A1 (en) * | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US20070274861A1 (en) * | 2004-12-07 | 2007-11-29 | Roche Diagnostics Operations, Inc. | Membranes and methods for coating membranes |
| US20090123955A1 (en) * | 2004-12-13 | 2009-05-14 | Bayer Healthcare Llc | Size Self-Limiting Compositions and Test Devices for Measuring Analytes in Biological Fluids |
| US20100028920A1 (en) * | 2007-03-05 | 2010-02-04 | Advanced Liquid Logic, Inc. | Hydrogen Peroxide Droplet-Based Assays |
| US7867592B2 (en) | 2007-01-30 | 2011-01-11 | Eksigent Technologies, Inc. | Methods, compositions and devices, including electroosmotic pumps, comprising coated porous surfaces |
| US20110168645A1 (en) * | 2004-08-05 | 2011-07-14 | Akers Biosciences, Inc. | Method for preparing a fluid fraction from blood |
| US8152477B2 (en) | 2005-11-23 | 2012-04-10 | Eksigent Technologies, Llc | Electrokinetic pump designs and drug delivery systems |
| US8251672B2 (en) | 2007-12-11 | 2012-08-28 | Eksigent Technologies, Llc | Electrokinetic pump with fixed stroke volume |
| US8360993B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Method for body fluid sample extraction |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US8979511B2 (en) | 2011-05-05 | 2015-03-17 | Eksigent Technologies, Llc | Gel coupling diaphragm for electrokinetic delivery systems |
| US9089293B2 (en) | 2009-08-13 | 2015-07-28 | Roche Diabetes Care, Inc. | Test element for analyzing a body fluid |
| US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
| US9664668B2 (en) | 2012-05-03 | 2017-05-30 | Qualigen, Inc. | Whole blood analytic device and method therefor |
| US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
| US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
| US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
| US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
| US10772550B2 (en) | 2002-02-08 | 2020-09-15 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5592698A (en) * | 1978-12-31 | 1980-07-14 | Kyoto Daiichi Kagaku:Kk | Test strip for glucose determination |
| GB2120787B (en) * | 1982-05-26 | 1986-02-19 | Lilly Industries Ltd | Method of estimating feed additives |
| US4689309A (en) * | 1985-09-30 | 1987-08-25 | Miles Laboratories, Inc. | Test device, method of manufacturing same and method of determining a component in a sample |
| DE19834938C2 (de) * | 1998-07-29 | 2000-07-20 | Coty Bv | Verfahren zur kosmetischen Bräunungsbestimmung einer Selbstbräunungszusammensetzung und Test-Kit |
| US6696240B1 (en) | 1999-10-26 | 2004-02-24 | Micronix, Inc. | Capillary test strip to separate particulates |
| DE102004024432A1 (de) * | 2004-05-14 | 2005-12-08 | Tesa Ag | Verwendung einer Folie mit hydrophiler Oberfläche in medizinischen Diagnosestreifen |
| US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
-
1966
- 1966-11-22 DE DE1598153A patent/DE1598153C3/de not_active Expired
-
1967
- 1967-11-15 US US683129A patent/US3630957A/en not_active Expired - Lifetime
- 1967-11-20 GB GB52639/67A patent/GB1159627A/en not_active Expired
- 1967-11-20 CY CY789A patent/CY789A/xx unknown
- 1967-11-20 CH CH1617667A patent/CH480634A/de not_active IP Right Cessation
- 1967-11-20 GR GR670138283A patent/GR38283B/el unknown
- 1967-11-21 SE SE6715976A patent/SE413439B/xx unknown
- 1967-11-21 FI FI673131A patent/FI48306C/fi active
- 1967-11-21 BR BR194865/67A patent/BR6794865D0/pt unknown
- 1967-11-21 AT AT1050867A patent/AT282832B/de not_active IP Right Cessation
- 1967-11-22 NL NL676715828A patent/NL145048B/xx not_active IP Right Cessation
- 1967-11-22 JP JP42074940A patent/JPS4933800B1/ja active Pending
Cited By (154)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3897214A (en) * | 1971-11-24 | 1975-07-29 | Boehringer Mannheim Gmbh | Diagnostic device |
| US3975162A (en) * | 1974-03-13 | 1976-08-17 | Marine Colloids, Inc. | Applying reagent to medium and device therefor |
| USRE30267E (en) * | 1975-06-20 | 1980-05-06 | Eastman Kodak Company | Multilayer analytical element |
| US4066403A (en) * | 1975-06-20 | 1978-01-03 | Eastman Kodak Company | Multilayer analytical element |
| US4020006A (en) * | 1975-08-14 | 1977-04-26 | Icl/Scientific | Fluid containing dispersed particles simulating leukocytes and method for producing same |
| US4935347A (en) * | 1976-01-12 | 1990-06-19 | Radiometer Corporate Development Ltd. | Stabilization of compounds |
| DE2614192A1 (de) * | 1976-04-02 | 1977-10-20 | Marine Colloids Inc | Analysenvorrichtung und analysenverfahren |
| US4283491A (en) * | 1977-09-06 | 1981-08-11 | Eastman Kodak Company | Analytical elements with improved reagent stability |
| DE2950501C1 (de) * | 1978-05-17 | 1983-07-07 | Battelle Memorial Institute, 1227 Carouge, Genève | Teststreifan |
| US4175923A (en) * | 1978-06-26 | 1979-11-27 | Friend William G | Method and apparatus for occult blood testing in the home |
| US4298498A (en) * | 1978-12-21 | 1981-11-03 | Boehringer Mannheim Gmbh | Control reagent for test strips for determining urobilinogen in urine |
| US4312834A (en) * | 1979-03-15 | 1982-01-26 | Boehringer Mannheim Gmbh | Diagnostic agent for the detection of component materials in liquid and process for producing same |
| US4388271A (en) * | 1980-01-10 | 1983-06-14 | Rohm Gmbh | Rapid diagnostic agents |
| US4303753A (en) * | 1980-03-20 | 1981-12-01 | Miles Laboratories, Inc. | Method and device for the semiquantitative determination of glucose in aqueous fluids |
| US4734375A (en) * | 1980-05-27 | 1988-03-29 | Miles Laboratories, Inc. | Ion specific test method |
| US4816224A (en) * | 1980-08-05 | 1989-03-28 | Boehringer Mannheim Gmbh | Device for separating plasma or serum from whole blood and analyzing the same |
| US4318985A (en) * | 1981-01-29 | 1982-03-09 | Miles Laboratories, Inc. | Method and device for detecting glucose concentration |
| US4587099A (en) * | 1981-05-09 | 1986-05-06 | Boehringer Mannheim Gmbh | Test strips for the detection of a liquid sample component |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| EP0110173A1 (en) | 1982-11-01 | 1984-06-13 | Lifescan, Inc. | Test device and method for in a colored aqueous fluid by diffuse reflectance detecting a soluble analyte measurement |
| US4820489A (en) * | 1982-12-23 | 1989-04-11 | Boehringer Mannheim Gmbh | Test strips and a process for the production thereof |
| US4582811A (en) * | 1983-02-02 | 1986-04-15 | Australian Monoclonal Development Pty. Ltd. | Method and diagnostic aid for detecting occult faecal blood |
| US4803158A (en) * | 1983-03-08 | 1989-02-07 | Kabushiki Kaisha Kyoto Daiichi Kagaku | Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition |
| US4645744A (en) * | 1983-05-12 | 1987-02-24 | Miles Laboratories, Inc. | Unified test means for ion determination |
| US4543338A (en) * | 1983-06-03 | 1985-09-24 | Miles Laboratories, Inc. | Wipe-off test device |
| US5055195A (en) * | 1983-07-02 | 1991-10-08 | Boehringer Mannheim Gmbh | Erythrocyte-retention substrates |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US4670218A (en) * | 1984-02-24 | 1987-06-02 | Miles Laboratories, Inc. | Ion test means having a porous carrier matrix |
| US4810633A (en) * | 1984-06-04 | 1989-03-07 | Miles Inc. | Enzymatic ethanol test |
| US4966855A (en) * | 1984-07-07 | 1990-10-30 | Boehringer Mannheim Gmbh | New redox indicators |
| US4780411A (en) * | 1984-09-22 | 1988-10-25 | Bayer Aktiengesellschaft | Water-absorbing, essentially water-free membrane for reagent substrates and methods of preparing the same |
| US4621049A (en) * | 1984-11-19 | 1986-11-04 | Miles Laboratories, Inc. | Enzymatic high range glucose test |
| US4895704A (en) * | 1985-04-23 | 1990-01-23 | Fuji Photo Film Co., Ltd. | Integral multilayer analytical element |
| SG83640A1 (en) * | 1986-08-13 | 2001-10-16 | Lifescan Inc | Method of operation of reflectance-reading devices |
| CN1036867C (zh) * | 1986-08-13 | 1997-12-31 | 生命扫描有限公司 | 一种在反射比读数装置中启动计时测量的方法 |
| US6858401B2 (en) | 1986-08-13 | 2005-02-22 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5563042A (en) * | 1986-08-13 | 1996-10-08 | Lifescan, Inc. | Whole blood glucose test strip |
| US5304468A (en) * | 1986-08-13 | 1994-04-19 | Lifescan, Inc. | Reagent test strip and apparatus for determination of blood glucose |
| US6821483B2 (en) | 1986-08-13 | 2004-11-23 | Lifescan, Inc. | Reagents test strip with alignment notch |
| US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5179005A (en) * | 1986-08-13 | 1993-01-12 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US6268162B1 (en) | 1986-08-13 | 2001-07-31 | Lifescan, Inc. | Reflectance measurement of analyte concentration with automatic initiation of timing |
| US5843692A (en) * | 1986-08-13 | 1998-12-01 | Lifescan, Inc. | Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood |
| US6887426B2 (en) | 1986-08-13 | 2005-05-03 | Roger Phillips | Reagents test strip adapted for receiving an unmeasured sample while in use in an apparatus |
| US6881550B2 (en) | 1986-08-13 | 2005-04-19 | Roger Phillips | Method for the determination of glucose employing an apparatus emplaced matrix |
| WO1988005912A1 (en) * | 1987-01-28 | 1988-08-11 | Technimed Corporation | Dry reagent delivery system |
| US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US4883764A (en) * | 1987-07-20 | 1989-11-28 | Kloepfer Mary A | Blood test strip |
| US4994238A (en) * | 1988-06-09 | 1991-02-19 | Daffern George M | Constant volume chemical analysis test device |
| US5304467A (en) * | 1988-11-30 | 1994-04-19 | Kyoto Daiichi Kagaku Co., Ltd. | Device for assay of liquid sample |
| EP0371513A2 (en) | 1988-12-01 | 1990-06-06 | Kyoto Daiichi Kagaku Co., Ltd. | Device and method for assay of liquid sample |
| US5106757A (en) * | 1989-02-25 | 1992-04-21 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Process for the visualization of substance stains on layer chromatograms |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5536470A (en) * | 1991-02-28 | 1996-07-16 | Boehringer Mannheim Gmbh | Test carrier for determining an analyte in whole blood |
| US5106581A (en) * | 1991-05-30 | 1992-04-21 | Industrial Test Systems, Inc. | Test device for detection of molybdate, vanadate and ferric ions |
| US5186843A (en) * | 1991-07-22 | 1993-02-16 | Ahlstrom Filtration, Inc. | Blood separation media and method for separating plasma from whole blood |
| US5766552A (en) * | 1993-04-20 | 1998-06-16 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
| US5660798A (en) * | 1993-04-20 | 1997-08-26 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
| US5681529A (en) * | 1994-08-25 | 1997-10-28 | Nihon Medi-Physics Co., Ltd. | Biological fluid analyzing device |
| US6818180B2 (en) | 1996-04-05 | 2004-11-16 | Roche Diagnostics Operations, Inc. | Devices for testing for the presence and/or concentration of an analyte in a body fluid |
| US5962215A (en) * | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
| US6036919A (en) * | 1996-07-23 | 2000-03-14 | Roche Diagnostic Gmbh | Diagnostic test carrier with multilayer field |
| US7560288B2 (en) | 1997-06-10 | 2009-07-14 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
| US20070048878A1 (en) * | 1997-06-10 | 2007-03-01 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
| US7049130B2 (en) | 1997-06-10 | 2006-05-23 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
| DE19826957C2 (de) * | 1997-06-17 | 2001-11-08 | Mercury Diagnostics Inc | Vorrichtung zum Bestimmen eines Analyten in einem Körperfluid |
| US6069011A (en) * | 1997-12-10 | 2000-05-30 | Umm Electronics, Inc. | Method for determining the application of a sample fluid on an analyte strip using first and second derivatives |
| US6162397A (en) * | 1998-08-13 | 2000-12-19 | Lifescan, Inc. | Visual blood glucose test strip |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US6979571B2 (en) | 1999-11-24 | 2005-12-27 | Home Diagnostics, Inc. | Method of using a protective test strip platform for optical meter apparatus |
| US6635439B2 (en) | 2000-12-21 | 2003-10-21 | Ethicon, Inc. | Hydrogen peroxide indicator employing enzyme and dye |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US7390665B2 (en) | 2001-02-28 | 2008-06-24 | Gilmour Steven B | Distinguishing test types through spectral analysis |
| US7476202B2 (en) | 2001-06-08 | 2009-01-13 | Roche Diagnostics Operations, Inc. | Sampling devices and methods utilizing a horizontal capillary test strip |
| US20040116829A1 (en) * | 2001-06-08 | 2004-06-17 | Raney Charles C. | Sampling devices and methods utilizing a horizontal capillary test strip |
| US6844149B2 (en) | 2001-06-29 | 2005-01-18 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| US20030003522A1 (en) * | 2001-06-29 | 2003-01-02 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| US20050039747A1 (en) * | 2001-09-24 | 2005-02-24 | Fukunaga Atsuo F. | Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases |
| US20030098661A1 (en) * | 2001-11-29 | 2003-05-29 | Ken Stewart-Smith | Control system for vehicle seats |
| US10772550B2 (en) | 2002-02-08 | 2020-09-15 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
| US7517440B2 (en) | 2002-07-17 | 2009-04-14 | Eksigent Technologies Llc | Electrokinetic delivery systems, devices and methods |
| US20050247558A1 (en) * | 2002-07-17 | 2005-11-10 | Anex Deon S | Electrokinetic delivery systems, devices and methods |
| US8715480B2 (en) | 2002-10-18 | 2014-05-06 | Eksigent Technologies, Llc | Electrokinetic pump having capacitive electrodes |
| US20040074784A1 (en) * | 2002-10-18 | 2004-04-22 | Anex Deon S. | Electrokinetic device having capacitive electrodes |
| US7235164B2 (en) | 2002-10-18 | 2007-06-26 | Eksigent Technologies, Llc | Electrokinetic pump having capacitive electrodes |
| US7267753B2 (en) | 2002-10-18 | 2007-09-11 | Eksigent Technologies Llc | Electrokinetic device having capacitive electrodes |
| US20040074768A1 (en) * | 2002-10-18 | 2004-04-22 | Anex Deon S. | Electrokinetic pump having capacitive electrodes |
| US7875159B2 (en) | 2002-10-18 | 2011-01-25 | Eksigent Technologies, Llc | Electrokinetic pump having capacitive electrodes |
| US8192604B2 (en) | 2002-10-18 | 2012-06-05 | Eksigent Technologies, Llc | Electrokinetic pump having capacitive electrodes |
| US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
| US20050202567A1 (en) * | 2003-03-24 | 2005-09-15 | Zanzucchi Peter J. | Analyte concentration detection devices and methods |
| US20040191119A1 (en) * | 2003-03-24 | 2004-09-30 | Zanzucchi Peter J. | Analyte concentration detection devices and methods |
| US8231832B2 (en) | 2003-03-24 | 2012-07-31 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
| US7427377B2 (en) | 2003-03-24 | 2008-09-23 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
| US9095292B2 (en) | 2003-03-24 | 2015-08-04 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
| US20050230080A1 (en) * | 2004-04-19 | 2005-10-20 | Paul Phillip H | Electrokinetic pump driven heat transfer system |
| US7559356B2 (en) | 2004-04-19 | 2009-07-14 | Eksident Technologies, Inc. | Electrokinetic pump driven heat transfer system |
| US20110168645A1 (en) * | 2004-08-05 | 2011-07-14 | Akers Biosciences, Inc. | Method for preparing a fluid fraction from blood |
| US8097171B2 (en) | 2004-08-05 | 2012-01-17 | Akers Biosciences, Inc. | Method of separating a fluid fraction from whole blood |
| US7955563B2 (en) | 2004-12-07 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Methods for applying reactive films containing solids to microporous membranes and membranes produced therefrom |
| US8202490B2 (en) | 2004-12-07 | 2012-06-19 | Roche Diagnostics Operations, Inc. | Membranes and methods for coating membranes |
| US20070274861A1 (en) * | 2004-12-07 | 2007-11-29 | Roche Diagnostics Operations, Inc. | Membranes and methods for coating membranes |
| US20110194980A1 (en) * | 2004-12-07 | 2011-08-11 | Roche Diagnostics Operations, Inc. | Process For Hydrophilizing Surfaces Of Fluidic Components And Systems |
| US20090123955A1 (en) * | 2004-12-13 | 2009-05-14 | Bayer Healthcare Llc | Size Self-Limiting Compositions and Test Devices for Measuring Analytes in Biological Fluids |
| US7964372B2 (en) | 2004-12-13 | 2011-06-21 | Bayer Healthcare Llc | Size self-limiting compositions and test devices for measuring analytes in biological fluids |
| US9982289B2 (en) | 2004-12-13 | 2018-05-29 | Ascensia Diabetes Care Holdings Ag | Size self-limiting compositions and test devices for measuring analytes in biological fluids |
| US9366636B2 (en) | 2005-06-13 | 2016-06-14 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US11419532B2 (en) | 2005-06-13 | 2022-08-23 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US20060281187A1 (en) * | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US10226208B2 (en) | 2005-06-13 | 2019-03-12 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US8969097B2 (en) | 2005-06-13 | 2015-03-03 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit-volume correction and feedback control |
| US10441205B2 (en) | 2005-09-30 | 2019-10-15 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
| US9839384B2 (en) | 2005-09-30 | 2017-12-12 | Intuity Medical, Inc. | Body fluid sampling arrangements |
| US8795201B2 (en) | 2005-09-30 | 2014-08-05 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| US10433780B2 (en) | 2005-09-30 | 2019-10-08 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
| US8360994B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Arrangement for body fluid sample extraction |
| US9060723B2 (en) | 2005-09-30 | 2015-06-23 | Intuity Medical, Inc. | Body fluid sampling arrangements |
| US8360993B2 (en) | 2005-09-30 | 2013-01-29 | Intuity Medical, Inc. | Method for body fluid sample extraction |
| US10842427B2 (en) | 2005-09-30 | 2020-11-24 | Intuity Medical, Inc. | Body fluid sampling arrangements |
| US11986298B2 (en) | 2005-09-30 | 2024-05-21 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| US9380974B2 (en) | 2005-09-30 | 2016-07-05 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
| US8794929B2 (en) | 2005-11-23 | 2014-08-05 | Eksigent Technologies Llc | Electrokinetic pump designs and drug delivery systems |
| US8152477B2 (en) | 2005-11-23 | 2012-04-10 | Eksigent Technologies, Llc | Electrokinetic pump designs and drug delivery systems |
| US7867592B2 (en) | 2007-01-30 | 2011-01-11 | Eksigent Technologies, Inc. | Methods, compositions and devices, including electroosmotic pumps, comprising coated porous surfaces |
| US8426213B2 (en) * | 2007-03-05 | 2013-04-23 | Advanced Liquid Logic Inc | Hydrogen peroxide droplet-based assays |
| US20100028920A1 (en) * | 2007-03-05 | 2010-02-04 | Advanced Liquid Logic, Inc. | Hydrogen Peroxide Droplet-Based Assays |
| US8251672B2 (en) | 2007-12-11 | 2012-08-28 | Eksigent Technologies, Llc | Electrokinetic pump with fixed stroke volume |
| US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
| US11045125B2 (en) | 2008-05-30 | 2021-06-29 | Intuity Medical, Inc. | Body fluid sampling device-sampling site interface |
| US11399744B2 (en) | 2008-06-06 | 2022-08-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
| US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
| US11986293B2 (en) | 2008-06-06 | 2024-05-21 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
| US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
| US11553860B2 (en) | 2008-06-06 | 2023-01-17 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
| US9089293B2 (en) | 2009-08-13 | 2015-07-28 | Roche Diabetes Care, Inc. | Test element for analyzing a body fluid |
| US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US11002743B2 (en) | 2009-11-30 | 2021-05-11 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US9897610B2 (en) | 2009-11-30 | 2018-02-20 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US11933789B2 (en) | 2009-11-30 | 2024-03-19 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
| US8979511B2 (en) | 2011-05-05 | 2015-03-17 | Eksigent Technologies, Llc | Gel coupling diaphragm for electrokinetic delivery systems |
| US11382544B2 (en) | 2011-08-03 | 2022-07-12 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US11672452B2 (en) | 2011-08-03 | 2023-06-13 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US11051734B2 (en) | 2011-08-03 | 2021-07-06 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US9664668B2 (en) | 2012-05-03 | 2017-05-30 | Qualigen, Inc. | Whole blood analytic device and method therefor |
| US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
Also Published As
| Publication number | Publication date |
|---|---|
| FI48306C (fi) | 1974-08-12 |
| CH480634A (de) | 1969-10-31 |
| DE1598153C3 (de) | 1973-11-22 |
| GB1159627A (en) | 1969-07-30 |
| DE1598153B2 (de) | 1973-05-03 |
| GR38283B (el) | 1969-10-17 |
| SE413439B (sv) | 1980-05-27 |
| NL145048B (nl) | 1975-02-17 |
| NL6715828A (enExample) | 1968-05-24 |
| AT282832B (de) | 1970-07-10 |
| FI48306B (enExample) | 1974-04-30 |
| CY789A (en) | 1976-06-01 |
| BR6794865D0 (pt) | 1973-03-20 |
| JPS4933800B1 (enExample) | 1974-09-10 |
| DE1598153A1 (de) | 1970-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3630957A (en) | Diagnostic agent | |
| US4312834A (en) | Diagnostic agent for the detection of component materials in liquid and process for producing same | |
| US3298789A (en) | Test article for the detection of glucose | |
| CA1219797A (en) | Test strips | |
| US3814668A (en) | Method and device for the semi-quantitative determination of glucose in aqueous fluids | |
| US3092465A (en) | Diagnostic test device for blood sugar | |
| JP5912213B2 (ja) | 生体液中の分析物を測定するためのサイズ自己制御式組成物および試験装置 | |
| US5128171A (en) | Method of making a test strip having a dialyzed polymer layer | |
| US3453180A (en) | Test article | |
| JPS60209174A (ja) | 液体試料の成分検出用の試験装置及び方法 | |
| DE3001669C2 (enExample) | ||
| US4231754A (en) | Chemiluminescent analytical device | |
| GB2026160A (en) | Test strip for determiation of glucose | |
| US5064615A (en) | Method and reagent for determining the ionic strength of specific gravity of aqueous liquids | |
| JPH0672878B2 (ja) | 透明な試験片系 | |
| US3630847A (en) | Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances | |
| US3654180A (en) | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| AU633210B2 (en) | Asymmetric sandwich membrane system as diagnostic test device | |
| CS207346B2 (en) | Chemical indication papers | |
| US3427225A (en) | Test composition,device and method for detecting urea in aqueous fluids | |
| Christie et al. | Direct electrochemical determination of paracetamol in plasma | |
| US3531254A (en) | Test article and method for the detection of urea | |
| JPH09105750A (ja) | ヘマトクリット値を補正した測定方法 | |
| Capitán-Vallvey et al. | Single-use optical sensor for the determination of iron in water and white wines | |
| JPS58193459A (ja) | アンモニアおよび尿素の分析具 |